{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:01:32Z","timestamp":1781798492135,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"vor","delay-in-days":9728,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1990,12]]},"DOI":"10.1111\/1523-1747.ep12875222","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T05:47:34Z","timestamp":1089870454000},"page":"S166-S169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S","title":["Interferon in the Treatment of AIDS-Associated Kaposi's Sarcoma: The American Experience"],"prefix":"10.1016","volume":"95","author":[{"given":"Bijan","family":"Safai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Bason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lordes","family":"Nisce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Friedman-Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12875222_bb0010","first-page":"305","article-title":"Centers for Disease Control: Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men\u2013New York City and California","volume":"30","year":"1981","journal-title":"MMWR"},{"key":"10.1111\/1523-1747.ep12875222_bb0015","first-page":"62","article-title":"Kaposi's sacoma: a review and recent developments","volume":"10","author":"Safai","year":"1980","journal-title":"Clin Bull"},{"key":"10.1111\/1523-1747.ep12875222_bb0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9343(79)90731-9","article-title":"Kaposi's sarcoma in recipients of renal transplants","volume":"67","author":"Harwood","year":"1979","journal-title":"Am J Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archderm.1974.01630100058014","article-title":"Kaposi's sarcoma complicating systemic lupus erythematosus treated with immunosuppression","volume":"110","author":"Klein","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12875222_bb0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM198309083091011","article-title":"AIDS\u2013two years later","volume":"309","author":"Curran","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM198201283060432","article-title":"Epidemiologic aspects of the current out-break of Kaposi's sarcoma and opportunistic infections","volume":"306","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ijc.2910220204","article-title":"Antibody patterns to herpes viruses in Kaposi's sarcoma II: serological association of American Kaposi's sarcoma with cytomegalovirus","volume":"22","author":"Giraldo","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1111\/1523-1747.ep12875222_bb0045","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/1097-0142(19800315)45:6<1472::AID-CNCR2820450629>3.0.CO;2-A","article-title":"Association of Kaposi's sarcoma with second malignancies, possible etiopathogenic implications","volume":"45","author":"Safai","year":"1980","journal-title":"Cancer (Philadelphia)"},{"key":"10.1111\/1523-1747.ep12875222_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3322\/canjclin.31.1.2","article-title":"Kaposi's sarcoma: a review and recent development","volume":"31","author":"Safai","year":"1981","journal-title":"CA\u2013Cancer J Clinicians"},{"key":"10.1111\/1523-1747.ep12875222_bb0055","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM197906143002401","article-title":"Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation: effects on cytomegalovirus and herpes simplex viral infections","volume":"300","author":"Cheesman","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0060","first-page":"299","article-title":"Interferons: Biochemical, cell growth inhibitory, and immunological effects","volume":"12","author":"Borden","year":"1981","journal-title":"Prog Hematol"},{"key":"10.1111\/1523-1747.ep12875222_bb0065","first-page":"4948","article-title":"Comparative antiproliferative activity in vitro of natural interferons A and B for diploid and transformed human cells","volume":"42","author":"Borden","year":"1982","journal-title":"Cancer Res"},{"key":"10.1111\/1523-1747.ep12875222_bb0070","first-page":"258","article-title":"The role of interferon in cell therapy: a current perspective","volume":"38","author":"Goldstein","year":"1988","journal-title":"CA"},{"key":"10.1111\/1523-1747.ep12875222_bb0075","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJM198305053081806","article-title":"Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma","volume":"308","author":"Krown","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0080","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/JCO.1986.4.4.544","article-title":"Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon","volume":"4","author":"Real","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875222_bb0085","first-page":"3","article-title":"Interferon alpha-2a \u00b1 vinblastine (VLB) in AIDS-associated Kaposi's sarcoma (KS\/AIDS): therapeutic activity, toxicity and effects on HTLV-III\/LAV viremia (abstr)","volume":"6","author":"Krown","year":"1986","journal-title":"J Interferon Res"},{"key":"10.1111\/1523-1747.ep12875222_bb0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-100-5-671","article-title":"Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with acquired immunodeficiency syndrome","volume":"100","author":"Groopman","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1749-6632.1984.tb37165.x","article-title":"Alpha interferon therapy of Kaposi's sarcoma in AIDS","volume":"437","author":"Volberding","year":"1984","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/1523-1747.ep12875222_bb0100","first-page":"51","article-title":"High-dose alpha-2 recombinant interferon in the therapy of epidemic Kaposi's sarcoma (KS) in acquired immune deficiency (AIDS) (abstr)","volume":"3","author":"Mitsuyasu","year":"1984","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875222_bb0105","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/1097-0142(19870201)59:3+<620::AID-CNCR2820591309>3.0.CO;2-5","article-title":"Treatment of Kaposi's sarcoma with interferon alpha-2b (Intron A)","volume":"59","author":"Volberding","year":"1987","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12875222_bb0110","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0002-9343(85)90276-1","article-title":"Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters","volume":"78","author":"Gelmann","year":"1985","journal-title":"Am J Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0115","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.1985.3.4.506","article-title":"Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma with lymphoblastoid interferon","volume":"3","author":"Rios","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875222_bb0120","first-page":"4","article-title":"Interferon alfa-N1 Wellferon (WFN) in Kaposi's sarcoma: Single agent or combination with vinblastine (VLB) (abstr)","volume":"6","author":"Fischl","year":"1986","journal-title":"J Interferon Res"},{"key":"10.1111\/1523-1747.ep12875222_bb0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-111-4-280","article-title":"Combined Zidovudine and interferon-A therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)","volume":"111","author":"Kovacs","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-103-5-744","article-title":"The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome","volume":"103","author":"Safai","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1111\/1523-1747.ep12875222_bb0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1749-6632.1984.tb37164.x","article-title":"Recombinant leukocyte A interferon in Kaposi's sarcoma","volume":"437","author":"Krown","year":"1984","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/1523-1747.ep12875222_bb0140","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(88)90811-2","article-title":"Anti-retroviral effects of interferon-A in AIDS-associated Kaposi's sarcoma","volume":"2","author":"Lane","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12875222_bb0145","first-page":"531","article-title":"Kaposi's sarcoma: a new staging classification","volume":"67","author":"Krigel","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/1523-1747.ep12875222_bb0150","first-page":"53","article-title":"Biology and therapy of Kaposi's sarcoma","volume":"11","author":"Mitsuyasu","year":"1984","journal-title":"Semin Oncol"},{"key":"10.1111\/1523-1747.ep12875222_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(83)91583-0","article-title":"Generalized Kaposi's sarcoma is not a neoplasm","volume":"1","author":"Costa","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12875222_bb0160","first-page":"315","article-title":"Kaposi's sarcoma","author":"Templeton","year":"1981","journal-title":"Pathol Annu"},{"key":"10.1111\/1523-1747.ep12875222_bb0165","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0140-6736(85)92144-0","article-title":"Recombinant human interferon alpha\u2013A suppresses HTLV-III replication in vitro","volume":"1","author":"Ho","year":"1985","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12875222_bb0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jir.1986.6.143","article-title":"Human alpha and beta interferon but not gamma suppress the in vitro replication of LAV, HTLV-III and ARV-2","volume":"6","author":"Yamamoto","year":"1986","journal-title":"J Interferon Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9091214V?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9091214V?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T08:23:38Z","timestamp":1698740618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X9091214V"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["S0022202X9091214V"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12875222","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1990,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon in the Treatment of AIDS-Associated Kaposi's Sarcoma: The American Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1523-1747.ep12875222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1990 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}